Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vericat

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|February 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic ReviewOctavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria, et al.
Thrombosis and Haemostasis|July 30, 2020
Common Genetic Variants in ABO and CLEC4M Modulate the Pharmacokinetics of Recombinant FVIII in Severe Hemophilia A PatientsIris Garcia-Martínez, Nina Borràs, Marta Martorell, et al.
Hematology Reports|October 28, 2025
Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A PatientsMaria Choví-Trull, Juan Eduardo Megías-Vericat, Santiago Bonanad-Boix, et al.
The Journal of Physical Chemistry. B|March 17, 2006
Two-site adsorption model for the (square root 3 x square root 3)-R30 degrees dodecanethiolate lattice on Au(111) surfacesXavier Torrelles, Carolina Vericat, María Elena Vela, et al.
Thrombosis Research|July 22, 2021
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patientsJuan Eduardo Megías-Vericat, Santiago Bonanad, Saturnino Haya, et al.
Nanoscale|February 16, 2011
"Naked" gold nanoparticles supported on HOPG: melanin functionalization and catalytic activityA González Orive, D Grumelli, C Vericat, et al.
Journal of the Neurological Sciences|June 12, 2016
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patientsAna Alejandra García-Robles, María José Company-Albir, Juan Eduardo Megías-Vericat, et al.
Pharmacogenomics|June 25, 2015
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantationIgnacio Sánchez-Lázaro, María José Herrero, Consuelo Jordán-De Luna, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 21, 2009
Neuronal in vitro models for the estimation of acute systemic toxicityA Forsby, A K Bal-Price, A Camins, et al.
The Pharmacogenomics Journal|May 10, 2017
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapyJ E Megías-Vericat, P Montesinos, M J Herrero, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|February 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic ReviewOctavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria, et al.
Thrombosis and Haemostasis|July 30, 2020
Common Genetic Variants in ABO and CLEC4M Modulate the Pharmacokinetics of Recombinant FVIII in Severe Hemophilia A PatientsIris Garcia-Martínez, Nina Borràs, Marta Martorell, et al.
Hematology Reports|October 28, 2025
Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A PatientsMaria Choví-Trull, Juan Eduardo Megías-Vericat, Santiago Bonanad-Boix, et al.
The Journal of Physical Chemistry. B|March 17, 2006
Two-site adsorption model for the (square root 3 x square root 3)-R30 degrees dodecanethiolate lattice on Au(111) surfacesXavier Torrelles, Carolina Vericat, María Elena Vela, et al.
Thrombosis Research|July 22, 2021
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patientsJuan Eduardo Megías-Vericat, Santiago Bonanad, Saturnino Haya, et al.
Nanoscale|February 16, 2011
"Naked" gold nanoparticles supported on HOPG: melanin functionalization and catalytic activityA González Orive, D Grumelli, C Vericat, et al.
Journal of the Neurological Sciences|June 12, 2016
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patientsAna Alejandra García-Robles, María José Company-Albir, Juan Eduardo Megías-Vericat, et al.
Pharmacogenomics|June 25, 2015
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantationIgnacio Sánchez-Lázaro, María José Herrero, Consuelo Jordán-De Luna, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 21, 2009
Neuronal in vitro models for the estimation of acute systemic toxicityA Forsby, A K Bal-Price, A Camins, et al.
The Pharmacogenomics Journal|May 10, 2017
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapyJ E Megías-Vericat, P Montesinos, M J Herrero, et al.
Pageof 20